Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode

Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode

Currently, there is a lack of pharmacogenetic research of antipsychotics’ safety in children and adolescents with acute psychotic episodes. Genetic polymorphisms of CYP2D6 and ABCB1 are the most likely candidates for such studies. AIM.To establish possible associations of CYP3A, CYP2D6, ABCB1 polymo...

Full description

Bibliographic Details
Main Authors:	D. V. Ivashchenko, N. I. Buromskaya, P. V. Shimanov, D. V. Deitch., K. A. Ryzhykova, Е. A. Grishina, Yu. S. Shevchenko, D. A. Sychev
Format:	Article
Language:	Russian
Published:	Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2019-12-01
Series:	Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:	pharmacogenetics, antipsychotics, safety, adolescents, acute psychotic episode
Online Access:	https://www.bekhterevreview.com/jour/article/view/312

Similar Items

The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study
by: D. V. Ivashchenko, et al.
Published: (2020-10-01)

Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
by: D. Ivashchenko, et al.
Published: (2022-06-01)

Off-label antipsychotics prescription to adolescents with acute psychotic episodes does not cause adverse drug reactions
by: D. V. Ivashchenko, et al.
Published: (2021-06-01)

Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol
by: Sergi Mas, et al.
Published: (2025-01-01)

Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients
by: Carrascal-Laso L, et al.
Published: (2021-08-01)

Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes
by: D. V. Ivashchenko, et al.
Published: (2020-12-01)

Psychotic episode with onset in childhood and adolescence – Factors which may influence the outcome
by: C.-E. Stoica, et al.
Published: (2022-06-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
by: Olga Płaza, et al.
Published: (2022-12-01)

Pharmacogenetic markers of antipsychotic-induced weight gain: leptin and neuroepeptide Y
by: V. S. Dobrodeeva, et al.
Published: (2021-04-01)

Acceptance and Commitment Therapy for Patients with a First Psychotic Episode
by: Nikita V. Chernov, et al.
Published: (2021-12-01)

Pharmacogenetics of antipsychotic-induced metabolic disturbances: state-of-the-art
by: R. F. Nasyrova, et al.
Published: (2018-07-01)

Psychotic Episode and Schizophrenia in Slovakian Narcolepsy Database
by: Eva Feketeová, et al.
Published: (2022-12-01)

Synthetic cannabinoids induced psychotic episode as differential diagnostic challenge: clinical case
by: D. M. Safonov
Published: (2019-08-01)

Synthetic cannabinoids induced psychotic episode as differential diagnostic challenge: clinical case
by: D. M. Safonov
Published: (2019-08-01)

Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment
by: O.O. Khaustova, et al.
Published: (2024-04-01)

Antipsychotic prescribing choices in patients with First Episode Psychosis
by: J. Fallon, et al.
Published: (2022-06-01)

Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
by: José María Rico-Gomis, et al.
Published: (2016-07-01)

The first psychotic episode with religious delusion in adolescence and young adults: premanifest stage
by: V. Kaleda, et al.
Published: (2022-06-01)

Transient Psychotic Episode Induced by Helicobacter pylori Triple Therapy Treatment
by: Mitanshu Shah, et al.
Published: (2012-06-01)

Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia
by: Karolína Knížková, et al.
Published: (2024-09-01)

Dynamics of immune markers in different variants of post-psychotic depression after first-episode psychosis in young adult age
by: S. Zozulya, et al.
Published: (2022-06-01)

Involving of family members within the program of psychosocial support of women underwent primary psychotic episode
by: V. Baskina
Published: (2016-10-01)

Involving of family members within the program of psychosocial support of women underwent primary psychotic episode
by: V. Baskina
Published: (2016-10-01)

Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: The first meta-analysis of Russian prospective studies
by: D A Sychev, et al.
Published: (2014-04-01)

Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study
by: Julia Spaton Goppers, et al.
Published: (2023-05-01)

The Pharmacogenetics of Treatment with Quetiapine
by: María Ortega-Ruiz, et al.
Published: (2022-07-01)

Impaired olfactory function in bipolar disorder patients during acute episodes regardless of psychotic symptoms
by: Yingying Li, et al.
Published: (2023-10-01)

Individual psychological characteristics and features of coping with the disease in patients with the first psychotic episode and post-psychotic depression as targets for psychosocial interventions
by: E. Yu. Antokhin, et al.
Published: (2023-07-01)

COST AND EFFECTIVENESS OF ATYPICAL-ATYPICAL ANTIPSYCHOTIC COMBINATIONS AND ATYPICAL-TYPICAL ANTIPSYCHOTIC COMBINATIONS IN PATIENTS OF PSYCHOTIC DISORDERS IN INSTALLATION OF EMERGENCY IN GRHASIA MENTAL HOSPITAL, YOGYAKARTA
by: Arya Dibyo Adisaputra, et al.
Published: (2021-11-01)

New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia
by: S. A. Ivanova
Published: (2019-12-01)

Prescription patterns of antipsychotics in the management of first episode psychosis at three psychiatric hospitals in Khartoum, 2018: A descriptive cross-sectional study
by: Malaz M A Mohamed, et al.
Published: (2020-01-01)

EFFECTIVE THERAPEUTIC INTERVENTIONS TO PROMOTE RECOVERY FROM FIRST PSYCHOTIC EPISODE AND MINIMIZE ITS RELAPSE: A QUALITATIVE STUDY FROM PAKISTAN
by: Rehana Khalil, et al.
Published: (2021-10-01)

No association of rs1065852 and rs3892097 polymorphisms gene CYP2D6 with treatment resistant schizophrenia
by: D. N. Sosin, et al.
Published: (2019-12-01)

A cross sectional study of trihexyphenidyl utilization on patient receiving antipsychotic therapy
by: Addiniya Nurul Azmi, et al.
Published: (2016-06-01)

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode
by: Milica Pjevac, et al.
Published: (2023-08-01)

Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01)

Executive function in adolescent patients with major depressive episode with psychotic symptoms and childhood trauma
by: Song Shiqi, et al.
Published: (2023-06-01)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
by: Zhang Cheng, et al.
Published: (2020-06-01)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
by: Emilia Vassilopoulou, et al.
Published: (2022-01-01)

Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
by: Antoine Baldacci, et al.
Published: (2023-10-01)